Table 1.
Baseline Characteristics of Patients With PLA
| Characteristics | All Patients (n = 125) | Nonmalignancy Subgroup (n = 65) | Malignancy Subgroup (n = 60) | P Values |
|---|---|---|---|---|
| Male, no. (%) | 85 (68) | 48 (74) | 37 (62) | .1447 |
| Age, mean (range) | 61 (13–92) | 58 (13–89) | 65 (40–92) | .021 |
| Race, no. (%) | .9545 | |||
| White | 123 (98) | 64 (98) | 59 (98) | |
| Nonwhite | 2 (2) | 1 (2) | 1 (2) | |
| Comorbidities, no. (%) | ||||
| Diabetes | 30 (24) | 18 (28) | 12 (20) | .3144 |
| Immunosuppression | 8 (6) | 5 (8) | 3 (5) | .5389 |
| IBD | 11 (9) | 8 (12) | 3 (5) | .1496 |
| Cirrhosis | 4 (3) | 4 (6) | 0 (0) | .1202 |
| Liver transplant | 1 (1) | 1 (2) | 0 (0) | 1 |
| Kidney disease | 6 (5) | 1 (2) | 5 (8) | .2096 |
| Biliary disease | 54 (43) | 30 (46) | 14 (23) | .0076 |
Abbreviations: IBD, inflammatory bowel disease; PLA, pyogenic liver abscesses.